ARTICLE | Management Tracks
George Eliades at the helm of Mythic
Plus: Michael Lenardo to become CSO at Calico, and updates from Aveo and Dyadic
March 28, 2024 11:53 PM UTC
Antibody-drug conjugate company Mythic Therapeutics Inc. named George Eliades president and CEO. Eliades was SVP of corporate development and chief transformation officer at Jazz Pharmaceuticals plc (NASDAQ:JAZZ).
Michael Lenardo will become CSO of Calico Life Sciences LLC in August. Lenardo is co-director of the NIH’s National Institute of Allergy and Infectious Diseases Clinical Genomics Program...